Molecular epidemiological surveillance and antifungal susceptibilities of Candida albicans strains isolated from anesthesia intensive care unit;Anestezi̇ yoǧun bakim üni̇tesi̇ hastalarindan i̇zole edi̇len Candida albicans suşlarinin anti̇fungal ajanlara duyarliliǧi ve moleküler epi̇demi̇yoloji̇k i̇zlemi̇

Mikrobiyoloji Bulteni

Volumn 36, Issue 3-4, 2002, Pages 309-316

  Gülay, Zeynep ^a   Ergon, Cem ^a   Özkütük, Aydan ^a   Yücesoy, Mine ^a   Biçmen, Meral ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Antifungal susceptibility; Candida albicans; Randomly amplified polymorphic DNA (RAPD)

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FUNGAL DNA;

ANESTHESIA; ARTICLE; CANDIDA ALBICANS; DILUTION; DRUG SENSITIVITY; EPIDEMIOLOGICAL DATA; GENE AMPLIFICATION; HOSPITAL INFECTION; HOSPITALIZATION; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RANDOM AMPLIFIED POLYMORPHIC DNA; URINALYSIS; VIRUS GENE; VIRUS ISOLATION; CANDIDIASIS; CHEMISTRY; CLASSIFICATION; CROSS INFECTION; DOSE RESPONSE; DRUG EFFECT; GENETICS; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; TURKEY (REPUBLIC); URINE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; CROSS INFECTION; DNA, FUNGAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUCONAZOLE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TURKEY; URINE;

EID: 0037832635     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fridkin SK, Jarvis WR: Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996, 9: 499-511.
2. Weinstein RA: Nosocomial infection update. Emerg Infect Dis 1998, 4: 416-420.
3. Beck-Sague CM, Jarvis WR, and the National Nosocomial Surveillance System: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993, 167: 1247-1251.
4. Pfaller MA: Epidemiological typing methods for mycoses. Clin Infect Dis 1992, 14 (Suppl): S4-S10.
5. Soil DR: The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 2000, 13: 332-370.
6. Robert F, Lebreton F, Bougnoux ME, et al: Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol 1995, 33: 2366-2371.
7. th ed. Amer Soc Microb, Washington DC.
8. th ed. Lippincott Company, Philadelphia.
9. Larone DH: Yeasts and yeast like organisms, pp: 61-89. In: Medically Important Fungi. 1995, 3rd ed. Amer Soc Microb, Washington DC.
10. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A. 1997, National Committee for Clinical Laboratory Standards, Wayne, Philadelphia.
11. Woods JP, Kersulyte D, Goldman WE, Berg DE: Fast DNA isolation from Histoplasma capsulatum: Methodology for arbitrary primer polymerase chain reaction-based epidemiological and clinical studies. J Clin Microbiol 1993, 31: 463-464.
12. Pujol C, Joly S, Lockhart SR, Noel S, Tibayrenc M, Soil DR: Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J Clin Microbiol 1997, 35: 2348-2358.
13. Holmberg K, Feroze F: Evaluation of an optimized system for random amplified polymorphic DNA (RAPD) analysis for genotypic mapping of Candida albicans strains. J Clin Lab Anal 1996, 10: 59-69.
14. King D, Chalberg JR, Pfaller MA, Moser SA, Merz WG: Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J Clin Microbiol 1995, 33: 1467-1470.
15. Arif S, Barkham T, Power EG, Howell SA: Techniques for investigation of an apparent outbreak of infections with Candida glabrata. J Clin Microbiol 1996, 34: 2205-2209.
16. Delabesse EB, Deventer H, Goessens W, et al: Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit. J Clin Microbiol 1995, 33: 3278-3283.
17. Lehmann PF, Lin D, Lasker BA: Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol 1992, 30: 3249-3254.
18. Marco F, Lockhart SR, Pfaller MA, et al: Elucidating the origins of nosocomial infections with C.albicans by DNA fingerprinting with the complex probe Ca3. J Clin Microbiol 1999, 37: 2817-2828.
19. Arnavielhe S, Blancard A, Mallie M, Quilici M, Bastide JM: Multilocus enzyme electrophoresis analysis of Candida albicans isolates from three intensive care units. An epidemiological study. Mycoses 1997, 40: 159-167.